Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network

FDA recall notice · announced November 16, 2016 · Wells Pharmacy Network

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network

Reason for recall

Superpotent and Subpotent drugs

Notes

Distribution: U.S.
Lot/code information: BUD: 10/04/2016, Lot number 04072016@40 BUD: 12/03/2016, Lot number 06162016@2 BUD: 01/07/2017, Lot number CA07112016@4
Quantity: 690 pellets
Status: Terminated
Products in this recall event:
- Testosterone Cholesterol ,100 mg Pellet, Compounded by: Wells Pharmacy Network (D-0127-2017)
- Testosterone 12.5 mg Pellet, Compounded by: Wells Pharmacy Network (D-0129-2017)
- Testosterone 200 mg/Anastrazole 20mg Pellet, Compounded by: Wells Pharmacy Network (D-0131-2017)
- Estradiol 12.5 mg Pellet, Compounded by: Wells Pharmacy Network (D-0132-2017)
- Estradiol 3 mg Pellet, Compounded by: Wells Pharmacy Network (D-0130-2017)
- Testosterone 60 mg/Anastrazole 4 mg Pellet, Compounded by: Wells Pharmacy Network (D-0128-2017)
- Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network (D-0126-2017)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.